Abstract-Resting heart rate is an easily measured, noninvasive vital sign that is associated with cardiovascular disease events. The pathophysiology of this association is not known. We investigated the relationship between resting heart rate and stiffness of the carotid (a peripheral artery) and the aorta (a central artery) in an asymptomatic multiethnic population. Resting heart rate was recorded at baseline in the Multi-Ethnic Study of Atherosclerosis (MESA). Distensibility was used as a measure of arterial elasticity, with a lower distensibility indicating an increase in arterial stiffness. Carotid distensibility was measured in 6484 participants (98% of participants) using B-mode ultrasound, and aortic distensibility was measured in 3512 participants (53% of participants) using cardiac MRI. Heart rate was divided into quintiles and we used progressively adjusted models that included terms for physical activity and atrioventricular nodal blocking agents. Mean resting heart rate of participants (mean age, 62 years; 47% men) was 63 bpm (SD, 9.6 bpm). In unadjusted and fully adjusted models, carotid distensibility and aortic distensibility decreased monotonically with increasing resting heart rate (P for trend <0.001 and 0.009, respectively). The relationship was stronger for carotid versus aortic distensibility. Similar results were seen using the resting heart rate taken at the time of MRI scanning.
R
esting heart rate is an attractive variable for risk stratification because it is a routinely collected, noninvasive vital sign that requires no special equipment for measurement. Several previous studies have demonstrated an association between an elevated resting heart rate and adverse cardiovascular disease events, cardiovascular death, and all-cause mortality. [1] [2] [3] [4] [5] It is still uncertain whether resting heart rate is a causative risk factor in cardiovascular disease. Cardiorespiratory fitness is a potential confounder because it is closely associated with both resting heart rate and cardiovascular mortality. 6 However, many studies have shown that resting heart rate predicts adverse events even after adjustment for physical activity. 3, 5, 7 In addition, the use of atrioventricular (AV) nodal blocking agents, such as β-blockers and nondihydropyridine calcium channel blockers, can pharmacologically lower heart rate and may also decrease cardiovascular disease.
An elevated resting heart rate is a common finding in patients with hypertension and those with subclinical diastolic dysfunction. 8, 9 We hypothesized that resting heart rate would be directly associated with a measure of stiffness in the carotid (peripheral) and aortic (central) arteries, and that this association would be independent of physical activity level and AV nodal blocker medication use.
Hypertension
September 2013 excluded if they did not have a resting heart rate value (n=49) or did not have a measurement of distensibility by either carotid ultrasound or cardiac MRI (n=143). Of these 6623 participants, carotid distensibility was not measured in 139 (2%) participants. Cardiac MRI was not performed in 1526 participants (23%) and aortic distensibility was not calculated in 1585 (24%) participants. After exclusions, there were 6484 participants with a measurement of carotid distensibility and 3512 participants with a measurement of aortic distensibility that were included in the analysis.
Resting Heart Rate and Distensibility Measurement
Participant resting heart rate was recorded from a resting 12-lead ECG performed at the baseline examination. Participants who underwent cardiac MRI scanning also had a separate heart rate measurement at the time of the scan. A separate heart rate was not recorded at the time of the carotid ultrasound. Distensibility was calculated separately for the carotid and aortic arteries, with a larger distensibility coefficient indicating a more elastic artery and a lower distensibility coefficient indicating a stiffer artery. Carotid distensibility was measured using B-mode ultrasound with a Logiq 700 machine (General Electric Medical Systems) at the baseline visit. Using these measurements carotid distensibility was calculated from the following equation 11 :
where ∆D is the change in systolic/diastolic diameter, ∆P the brachial pulse pressure, and D s is the systolic diameter. Three seated blood pressure measurements were performed at rest using a Dinamap Pro 100 automated sphygmomanometer and the mean values of the second and third measurements were recorded. Aortic distensibility was measured using 1.5T MRI scanners (3 sites used a Siemens Medical Solutions Symphony or Sonata and 3 sites used a General Electric Medical Systems CV/I or LX) with images of the descending thoracic aorta that were obtained at the level of the right pulmonary artery during mid-diastole. Aortic distensibility was evaluated using gradient-echo phase-contrast cine MRI with ECG gating and calculated using the following equation 12 : AD = − ( )     max aortic area min aortic area min aortic area pulse press sure.
Pulse pressure was calculated using the mean blood pressure value from immediately before and after MRI scanning while the participant was supine.
Study Covariates
All other covariates were obtained from the baseline MESA clinical examination. Hypertension was defined as a systolic blood pressure ≥140 mm Hg, a diastolic blood pressure ≥90 mm Hg, or the reported use of an anti-hypertensive medication; diabetes mellitus was defined as a fasting blood glucose ≥126 mg/dL or self-report of diabetes mellitus or self-report of taking glucose-lowering medications. Smoking status was defined as never, former, and current. Heavy drinkers were classified as men who consume >14 drinks/wk and women who consume >7 drinks/wk. Physical activity was measured in MESA using the Typical Week Physical Activity Survey, which assessed the frequency and time spent engaging in various physical activities. There were 28 questions about the typical weekly time spent and frequency engaged in activities, including household chores, yard work, leisure time, sports, and occupational activity. This included questions about light, moderate, and vigorous physical activity. Time spent in each activity was multiplied by the metabolic equivalent level to obtain MET-hours per week. We divided participants into approximate quartiles on the basis of reported moderate and vigorous physical activity. 13 Socioeconomic status was based on total household income and the highest attained level of education. Family history of coronary heart disease (CHD) was defined as a positive history of CHD in a parent, sibling, or child.
Statistical Analysis
We divided participants into resting heart rate quintiles to facilitate comparison with the previous heart rate literature. Distensibility was examined as a continuous variable using robust linear regression models. In addition, we performed secondary analysis using prevalence ratio regression models after dividing distensibility into quartiles. Results of these models were interpreted as the prevalence risk ratio of being in the least distensible quartile (stiffest group), with the most distensible quartile as the reference.
We used progressively adjusted models for these analyses. Model 1 included age, sex, and ethnicity. Model 2 added body mass index, waist circumference, total household income, highest attained level of education, systolic blood pressure, diastolic blood pressure, pulse pressure, antihypertensive medication use, smoking status, low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, triglycerides, lipid-lowering medication use, high sensitivity C-reactive protein (hs-CRP), and family history of CHD. Model 3 added physical activity level and AV nodal medication use.
We then performed subgroup sensitivity analyses modeling the prevalence ratio regression of being in the least distensible quartile per SD change (7.9 bpm) in distensibility. In addition, to determine the relative impact of baseline clinical resting heart rate versus heart rate taking at the exact time of scanning, we modeled the association of heart rate difference (heart rate at time of MRI−resting heart rate at baseline clinical assessment) and arterial distensibility. The group of participants with minimal change in heart rate (±2 bpm) between the 2 measurements was considered as the reference. Participants with an absolute change in heart rate of 3 to 5 bpm and 6 to 20 bpm were defined as the comparison groups; we excluded the small group of individuals with an absolute heart rate change of 20 (outside of 2 SDs) from this analysis.
Results
At the baseline examination participants with higher resting heart rates were more likely to be older, diabetic, have higher blood pressure, body mass index, hs-CRP, and have calcification of the thoracic aorta on cardiac CT (Table 1) . Participants with lower resting heart rates were more likely to be men, take an AV nodal blocker medication, have a higher total household income, have more than a high school education, and have a higher reported physical activity level. Overall, the baseline characteristics of the 3512 participants with an aortic distensibility measurement were similar (Table S1 in the online-only Data Supplement).
Participants with lower resting heart rates had more distensible carotid and aortic arteries ( Figure 1 ). There was a significantly graded decrease in distensibility for both the carotid and aortic arteries (P for trend <0.001 and 0.004, respectively). The absolute difference in distensibility between Figure 1 . Distensibility of the carotid and aorta stratified by increasing baseline resting heart rate quintiles with SE bars, unadjusted.
by guest on July 7, 2017 http://hyper.ahajournals.org/ Downloaded from resting heart rate quintiles 1 and 5 was greater for the carotid artery (2.7-2.2 mm Hg×10 ). Carotid and aortic distensibility decreased with increasing heart rate even after adjustment for physical activity and AV nodal blocker use (P for trend <0.001 and 0.009, respectively; Tables 2 and 3 ). These β-coefficients represent small to moderate changes in stiffness. The relationship was stronger and more statistically significant for carotid artery distensibility.
Participants with higher resting heart rates also had an increased risk of being in the least distensible carotid and aortic quartiles (P for trend <0.001 and 0.017, respectively; Tables 4 and 5 ). The graded increased risk of being in the least distensible quartile was similar for both measurements, although the association was more robust for the carotid artery compared with the aorta (Figure 2 ). Moreover, for carotid distensibility the association was significant for all heart rate groups, whereas for aortic distensibility it was only significant for the highest heart rate group.
In subgroup analyses, elevated resting heart rate was more predictive of being in the least distensible quartile for participants >65 years and those without hypertension for carotid distensibility (Table 6 ). Elevated resting heart rate was more predictive of aortic distensibility for participants who were women, black, had hypertension, or diabetes mellitus. However, the differences in subgroup associations were not consistent between carotid and aortic distensibility. In addition, we performed all analyses for carotid ultrasound restricted to only those 3512 participants who had a measurement of aortic distensibility; there was no significant difference in the Data presented as mean and SD, unless otherwise indicated. AV indicates atrioventricular; BMI, body mass index; hs-CRP, high sensitivity C-reactive protein; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HR, heart rate; HTN, hypertensive; LDL, low-density lipoprotein; PA, physical activity; and SBP, systolic blood pressure.
*Mean and minimum to maximum values. †Median and interquartile range. ‡MET-hours/wk.
results. Because of concern for potential over adjustment, we performed analyses adjusting for hypertension, but not antihypertensive medication use in model 2. We also performed analyses adjusting for pack-years of smoking. There was no significant change in the results for these analyses. We also performed all analyses using heart rate as measured at the time of cardiac MRI and the overall results were similar. Participants whose heart rate was much lower (6-20 bpm) at the time of MRI compared with the clinical resting heart rate assessment were ≈30% more likely to be in the least distensible aortic quartile compared with those with a minimal change in heart rate between exams (Tables S2 and S3 ). There was no significant association between change in heart rate and aortic distensibility for participants whose heart rate was higher at the time of MRI scanning.
Discussion
Individuals with higher a resting heart rate are more likely to have decreased cardiorespiratory fitness, engage in less physical activity, and have an increased sympathetic tone and autonomic instability. 2, 6 Increased resting heart rate has been associated with traditional cardiovascular risk factors, adverse cardiovascular events, and cardiovascular mortality in many studies. 7, 14 Stiffening of both the medium-sized and the large elastic arteries is associated with aging, hypertension, diastolic dysfunction, and other traditional risk factors for atherosclerosis. [15] [16] [17] [18] [19] [20] Arterial stiffness itself is also associated with coronary artery calcium and has been demonstrated to predict the severity of atherosclerosis. [21] [22] [23] [24] [25] In addition, it is associated with adverse clinical events, such as stroke, 26 myocardial infarction, 27 heart failure, 28 and cardiovascular mortality. 29 Similar to other studies, our results demonstrate that a higher resting heart rate is associated with cardiovascular risk factors, including blood pressure, obesity, and decreased physical activity. In this analysis, we have also demonstrated that an increased resting heart rate is associated with a decreased arterial distensibility, which is one of the earliest detectable manifestations of adverse structural and functional changes within the vessel wall. 30 This robust association persisted after adjustment for traditional cardiovascular risk factors and AV nodal blocker medication use.
There are several biological mechanisms that may explain why individuals with higher resting heart rates are more likely to develop cardiovascular disease. Previous animal and human studies have suggested a casual association between resting heart rate and stiffness; however, these have not been fully replicated on a larger scale using modern imaging modalities. 31, 32 These results demonstrate that an increased heart rate is associated with a decreased dynamic compliance and increased mechanical stress that ultimately may lead to an increased stiffening of the arterial wall. This may be because of the progressively shorter amount of time available for arterial wall recoil as heart rate increases. 33 An increased heart rate also exerts a greater number of pulsatile strain cycles on the arterial wall, leading to an increased fatigue and fracture of the elastic fibers in the arterial wall, which is an important cause of age-related arterial stiffening. 34 There is also an increase in arterial pulsatile flow and shear stress, which can promote atherosclerotic lesion formation. 35, 36 Furthermore, a higher heart rate increases mean arterial pressure because of a reduction in the time spent in diastole and may physiologically be a compensatory The autonomic nervous system may also be an important common pathway that can influence both resting heart rate and arterial stiffness. Increased sympathetic activity has been shown to decrease arterial compliance in both medium and large muscular arteries. [37] [38] [39] This increase in arterial stiffness may be partially because of an increase in vasomotor tone. Vascular remodeling also occurs through the effect of sympathetic nervous system on the renin-angiotensin-aldosterone system, which results in smooth muscle hypertrophy, fibrosis, and reduced elastin synthesis. 40, 41 The significant association between increased heart rate and cardiovascular mortality has created interest in heart rate reduction as a potential therapeutic target. A reduction in heart rate by β-blockers has been demonstrated to reduce infarct size, decrease mortality after myocardial infarction, and reduce mortality in heart failure patients. 42, 43 However, in Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), there was no suggestion of increased relative benefit of atenolol over amlodipine in patients with increased heart rate. 44 Results from a meta-analysis of >68 000 individuals by Bangalore et al 45 also suggested that heart rate lowering with β-blockers in hypertensive patients was associated with increased mortality. The Morbidity-Mortality Evaluation of the If Inhibitor Ivabradine in Patients With Coronary Disease and Left Ventricular Dysfunction (BEAUTIFUL) trial investigated heart rate reduction using ivabradine, which decreases heart rate by directly acting on the sinoatrial node and unlike β-blockers does not have other cardiac effects. 46 There was no significant change in the composite primary outcome of cardiovascular death, admission for myocardial infarction, or admission for heart failure. In a follow-up study, the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) used ivabradine to lower heart rate beyond that achieved with β-blockers for participants with a resting heart rate of ≥70 bpm and found a 26% reduction in mortality from heart failure. 47 One explanation for the lack of an observed benefit within some of these trials is the inverse relationship between heart rate and central aortic pressures. 48 The Conduit Artery Function Evaluation (CAFE) trial investigated the effect of brachial blood pressure reduction with or without β-blockers on central aortic pressures and measured central aortic pressures using Augmentation Index. In a substudy investigating the association of heart rate reduction and Augmentation Index, there was a strong inverse association between heart rate and central aortic systolic and pulse pressure. 49 The increase in aortic stiffness may be because of pharmacological heart rate reduction leading to an increased wave reflection and subsequently increased central aortic pressure. A decreased heart rate also results in increased filling and stroke volume, which when ejected into stiffened arteries that have a reduced compliance causes an increase in central aortic and pulse pressures.
Strengths of this study include the multi-ethnic cohort, detailed measurement of anthropometric covariates, physical activity levels, and AV nodal blocker medication use. However, our results should be considered in light of certain limitations including the cross-sectional nature of our data. We were not able to assess the temporal relationship between resting heart rate and arterial distensibility, which precludes any conclusions with regard to causality. There were also significantly fewer participants with a measure of aortic distensibility compared Model 1: age, sex, and ethnicity. Model 2: model 1+body mass index, waist circumference, systolic blood pressure, diastolic blood pressure, pulse pressure, antihypertensive use, smoking, lowdensity lipoprotein-cholesterol, high-density lipoprotein-cholesterol, triglycerides, lipid-lowering use, high sensitivity C-reactive protein, family history of coronary heart disease, household income, educational attainment, and heavy alcohol use.
Model 3: model 2+physical activity level and atrioventricular nodal blocker use. with carotid distensibility. However, there were still 3512 participants with a measurement of aortic distensibility and when we limited our analyses to these participants there were no significant differences in the results. Our measurements of distensibility were performed using 2 different imaging techniques (ultrasound and cardiac MRI) which may limit the comparability of results. The 2 measurement sites also represent peripheral-muscular (carotid) and central-elastic (aortic) arteries, which have inherent differences that must be remembered when interpreting our findings. However, Lénárd et al 50 demonstrated that when measured using ultrasound there is strong correlation between carotid and aortic distensibility (r=0.81).
Similarly, Harloff et al 51 showed excellent agreement between ultrasound and MRI measurement of common carotid distensibility. In addition, the physical activity measurement quantified the participant-reported weekly intensity and duration of physical activity, but may not accurately reflect cardiovascular fitness as this was not directly measured in MESA.
Perspectives
Our analysis demonstrated a direct relationship between resting heart rate and arterial stiffness using modern imaging modalities in an ethnically diverse population free of known cardiovascular disease. Importantly, these results persist after adjustment for known cardiovascular risk factors, physical activity level, and AV nodal blocking medications. Our results suggest that an increased resting heart rate may be a useful noninvasive tool for inferring arterial stiffness and identifying a population at increased cardiovascular risk. Overall, these results provide evidence for a potential underlying mechanism to explain the association of an increased resting heart rate with adverse cardiovascular outcomes, and further study is needed to determine the potential causality of the association and whether resting heart rate reduction as a target of pharmacological treatment is useful for reducing cardiovascular events in asymptomatic patients. Prevalence ratio for being in the stiffest carotid or aortic distensibility quartile on the basis of baseline resting heart rate quintile.
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